Fondazione Michelangelo
9 clinical trials · Sponsor
◉ Watch Fondazione Michelangelo
| Record | Firm | Date |
|---|---|---|
| Neoadjuvant Treatment of HER2 Positive Early High-risk and Locally Advanced Breast Cancer (NCT03595592) | Fondazione Michelangelo | 2018-09-07 |
Track Fondazione Michelangelo automatically
Every clearance here is in the API, with alerts when new ones post.